Results
|
10021.
|
|
|
10022.
|
|
|
10023.
|
|
|
10024.
|
|
|
10025.
|
|
|
10026.
|
|
|
10027.
|
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. [electronic resource] by
- Gerlag, Danielle M
- Safy, Mary
- Maijer, Karen I
- Tang, Man Wai
- Tas, Sander W
- Starmans-Kool, Mirian J F
- van Tubergen, Astrid
- Janssen, Matthijs
- de Hair, Maria
- Hansson, Monika
- de Vries, Niek
- Zwinderman, Aeilko H
- Tak, Paul P
Producer: 20191028
In:
Annals of the rheumatic diseases vol. 78
Availability: No items available.
|
|
10028.
|
Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP. [electronic resource] by
- Umino, Kento
- Fujiwara, Shin-Ichiro
- Minakata, Daisuke
- Yamamoto, Chihiro
- Meguro, Akiko
- Matsuyama, Tomohiro
- Sato, Kazuya
- Ohmine, Ken
- Izumi, Tohru
- Muroi, Kazuo
- Kanda, Yoshinobu
Producer: 20200430
In:
Leukemia & lymphoma vol. 60
Availability: No items available.
|
|
10029.
|
|
|
10030.
|
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia. [electronic resource] by
- Bagacean, Cristina
- Tempescul, Adrian
- Ternant, David
- Banet, Anne
- Douet-Guilbert, Nathalie
- Bordron, Anne
- Bendaoud, Boutahar
- Saad, Hussam
- Zdrenghea, Mihnea
- Berthou, Christian
- Paintaud, Gilles
- Renaudineau, Yves
Producer: 20200527
In:
Journal for immunotherapy of cancer vol. 7
Availability: No items available.
|
|
10031.
|
|
|
10032.
|
IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages. [electronic resource] by
- Zhang, Meili
- Wen, Bernard
- Anton, Olga M
- Yao, Zhengsheng
- Dubois, Sigrid
- Ju, Wei
- Sato, Noriko
- DiLillo, David J
- Bamford, Richard N
- Ravetch, Jeffrey V
- Waldmann, Thomas A
Producer: 20190123
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 115
Availability: No items available.
|
|
10033.
|
|
|
10034.
|
|
|
10035.
|
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study. [electronic resource] by
- Candelaria, Myrna
- González, Derlis E
- Delamain, Marcia Torresan
- Bär, Daniel Oscar
- Beniwal, Surender Kumar
- Dasappa, Lokanatha
- Flores, David Hugo
- Querol, John
- Guan, Toh See
- Lipatov, Oleg Nikolaevich
- Volodicheva, Elena Mikhailovna
- Patel, Moosa
- Safaee Nodehi, Sayyed Reza
- Fogliatto, Laura
- Paravisini, Alexandra
- Perez Diaz, Luis
Producer: 20200918
In:
Leukemia & lymphoma vol. 60
Availability: No items available.
|
|
10036.
|
|
|
10037.
|
|
|
10038.
|
|
|
10039.
|
|
|
10040.
|
|